NCT03836209 2025-06-15Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid LeukemiaPrECOG, LLC.Phase 2 Active not recruiting181 enrolled 18 charts
NCT00819546 2025-02-27RAD001 in Combination With PKC412 in Patients With Relapsed, Refractory or Poor Prognosis AML or MDSDana-Farber Cancer InstitutePhase 1 Active not recruiting29 enrolled